106 related articles for article (PubMed ID: 22587915)
1. Expression of BMP-2 and Ets1 in BMP-2-stimulated mouse pre-osteoblast differentiation is regulated by microRNA-370.
Itoh T; Ando M; Tsukamasa Y; Akao Y
FEBS Lett; 2012 Jun; 586(12):1693-701. PubMed ID: 22587915
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-208 modulates BMP-2-stimulated mouse preosteoblast differentiation by directly targeting V-ets erythroblastosis virus E26 oncogene homolog 1.
Itoh T; Takeda S; Akao Y
J Biol Chem; 2010 Sep; 285(36):27745-52. PubMed ID: 20576608
[TBL] [Abstract][Full Text] [Related]
3. The suppressive effect of myeloid Elf-1-like factor (MEF) in osteogenic differentiation.
Kim YJ; Kim BG; Lee SJ; Lee HK; Lee SH; Ryoo HM; Cho JY
J Cell Physiol; 2007 Apr; 211(1):253-60. PubMed ID: 17167770
[TBL] [Abstract][Full Text] [Related]
4. Nanotopography directs mesenchymal stem cells to osteoblast lineage through regulation of microRNA-SMAD-BMP-2 circuit.
Kato RB; Roy B; De Oliveira FS; Ferraz EP; De Oliveira PT; Kemper AG; Hassan MQ; Rosa AL; Beloti MM
J Cell Physiol; 2014 Nov; 229(11):1690-6. PubMed ID: 24619927
[TBL] [Abstract][Full Text] [Related]
5. miRNA-133a-5p Inhibits the Expression of Osteoblast Differentiation-Associated Markers by Targeting the 3' UTR of RUNX2.
Zhang W; Wu Y; Shiozaki Y; Sugimoto Y; Takigawa T; Tanaka M; Matsukawa A; Ozaki T
DNA Cell Biol; 2018 Mar; 37(3):199-209. PubMed ID: 29359964
[TBL] [Abstract][Full Text] [Related]
6. miR-23b targets Smad 3 and ameliorates the LPS-inhibited osteogenic differentiation in preosteoblast MC3T3-E1 cells.
Liu H; Hao W; Wang X; Su H
J Toxicol Sci; 2016 Apr; 41(2):185-93. PubMed ID: 26961602
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein-3b (BMP-3b) inhibits osteoblast differentiation via Smad2/3 pathway by counteracting Smad1/5/8 signaling.
Matsumoto Y; Otsuka F; Hino J; Miyoshi T; Takano M; Miyazato M; Makino H; Kangawa K
Mol Cell Endocrinol; 2012 Mar; 350(1):78-86. PubMed ID: 22155034
[TBL] [Abstract][Full Text] [Related]
8. Ets transcription factors and targets in osteogenesis.
Raouf A; Seth A
Oncogene; 2000 Dec; 19(55):6455-63. PubMed ID: 11175361
[TBL] [Abstract][Full Text] [Related]
9. Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-alpha in C2C12 cells.
Matsumoto Y; Otsuka F; Takano M; Mukai T; Yamanaka R; Takeda M; Miyoshi T; Inagaki K; Sada KE; Makino H
Mol Cell Endocrinol; 2010 Aug; 325(1-2):118-27. PubMed ID: 20638987
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells.
Xiao G; Gopalakrishnan R; Jiang D; Reith E; Benson MD; Franceschi RT
J Bone Miner Res; 2002 Jan; 17(1):101-10. PubMed ID: 11771655
[TBL] [Abstract][Full Text] [Related]
11. Harmine promotes osteoblast differentiation through bone morphogenetic protein signaling.
Yonezawa T; Lee JW; Hibino A; Asai M; Hojo H; Cha BY; Teruya T; Nagai K; Chung UI; Yagasaki K; Woo JT
Biochem Biophys Res Commun; 2011 Jun; 409(2):260-5. PubMed ID: 21570953
[TBL] [Abstract][Full Text] [Related]
12. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation.
Lee MH; Javed A; Kim HJ; Shin HI; Gutierrez S; Choi JY; Rosen V; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Ryoo HM
J Cell Biochem; 1999 Apr; 73(1):114-25. PubMed ID: 10088730
[TBL] [Abstract][Full Text] [Related]
13. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
[TBL] [Abstract][Full Text] [Related]
14. Gene array analysis of bone morphogenetic protein type I receptor-induced osteoblast differentiation.
Korchynskyi O; Dechering KJ; Sijbers AM; Olijve W; ten Dijke P
J Bone Miner Res; 2003 Jul; 18(7):1177-85. PubMed ID: 12854827
[TBL] [Abstract][Full Text] [Related]
15. Gene array analysis of osteoblast differentiation.
Beck GR; Zerler B; Moran E
Cell Growth Differ; 2001 Feb; 12(2):61-83. PubMed ID: 11243467
[TBL] [Abstract][Full Text] [Related]
16. Homeodomain transcription factors regulate BMP-2-induced osteoactivin transcription in osteoblasts.
Singh M; Del Carpio-Cano FE; Monroy MA; Popoff SN; Safadi FF
J Cell Physiol; 2012 Jan; 227(1):390-9. PubMed ID: 21503878
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel regulators associated with early-phase osteoblast differentiation.
de Jong DS; Vaes BL; Dechering KJ; Feijen A; Hendriks JM; Wehrens R; Mummery CL; van Zoelen EJ; Olijve W; Steegenga WT
J Bone Miner Res; 2004 Jun; 19(6):947-58. PubMed ID: 15125793
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor activity is involved in the osteoblastic differentiation regulated by bone morphogenetic proteins and tumor necrosis factor-α.
Takano M; Otsuka F; Matsumoto Y; Inagaki K; Takeda M; Nakamura E; Tsukamoto N; Miyoshi T; Sada KE; Makino H
Mol Cell Endocrinol; 2012 Jan; 348(1):224-32. PubMed ID: 21888945
[TBL] [Abstract][Full Text] [Related]
19. Bone morphogenetic protein 2-induced osteoblast differentiation requires Smad-mediated down-regulation of Cdk6.
Ogasawara T; Kawaguchi H; Jinno S; Hoshi K; Itaka K; Takato T; Nakamura K; Okayama H
Mol Cell Biol; 2004 Aug; 24(15):6560-8. PubMed ID: 15254224
[TBL] [Abstract][Full Text] [Related]
20. BMP-2 promotes differentiation of osteoblasts and chondroblasts in Runx2-deficient cell lines.
Liu T; Gao Y; Sakamoto K; Minamizato T; Furukawa K; Tsukazaki T; Shibata Y; Bessho K; Komori T; Yamaguchi A
J Cell Physiol; 2007 Jun; 211(3):728-35. PubMed ID: 17226753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
